Literature DB >> 15084517

Angiogenesis in an in vivo model of adipose tissue development.

Jaap G Neels1, Terri Thinnes, David J Loskutoff.   

Abstract

Obesity is associated with an increased risk for cardiovascular disease and cancer. Angiogenesis is a critical component of these pathological processes, and expanding adipose tissue represents one of the few sites of active angiogenesis in the adult. Despite the potential importance of angiogenesis in obesity, little is known about underlying mechanisms. This problem is magnified by the absence of useful quantitative model systems. In this report, we examine the angiogenic process using the 3T3-F442A model of adipose tissue development. In this model, 3T3-F442A preadipocytes are implanted subcutaneously into athymic Balb/c nude mice. We show that these cells develop into highly vascularized fat pads over the next 14-21 days, and that these fat pads are morphologically similar to normal subcutaneous adipose tissue. Histological studies demonstrate that a new microvasculature is evident as early as 5 days after cell implantation, and real-time quantitative RT-PCR analyses show that the expression of endothelial cell markers and adipogenesis markers increase in parallel during fat pad development. Finally, these preliminary studies suggest that the neovasculature originates by sprouting from larger, host-derived blood vessels that run parallel to peripheral nerves and that endothelial progenitor cells play little, if any, role in this process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084517     DOI: 10.1096/fj.03-1101fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  44 in total

1.  Microvascular endothelial cells sustain preadipocyte viability under hypoxic conditions.

Authors:  Cynthia A Frye; Xuemei Wu; Charles W Patrick
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

2.  Inflamed fat: what starts the fire?

Authors:  Jaap G Neels; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice.

Authors:  Fen Xu; David Burk; Zhanguo Gao; Jun Yin; Xia Zhang; Jianping Weng; Jianping Ye
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

4.  In vitro 3D model for human vascularized adipose tissue.

Authors:  Jennifer H Kang; Jeffrey M Gimble; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2009-08       Impact factor: 3.845

5.  Angiogenesis modulates adipogenesis and obesity.

Authors:  Yihai Cao
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

6.  Human adipose tissue contains erythroid progenitors expressing fetal hemoglobin.

Authors:  Amparo Navarro; Francisco Carbonell-Uberos; Severiano Marín; María Dolores Miñana
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 7.  Bioengineering strategies to generate vascularized soft tissue grafts with sustained shape.

Authors:  Michael S Stosich; Eduardo K Moioli; June K Wu; Chang Hun Lee; Christine Rohde; Azizeh Mitra Yoursef; Jeffrey Ascherman; Robert Diraddo; Nicholas W Marion; Jeremy J Mao
Journal:  Methods       Date:  2008-10-24       Impact factor: 3.608

Review 8.  Obesity and cancer--mechanisms underlying tumour progression and recurrence.

Authors:  Jiyoung Park; Thomas S Morley; Min Kim; Deborah J Clegg; Philipp E Scherer
Journal:  Nat Rev Endocrinol       Date:  2014-06-17       Impact factor: 43.330

9.  Vascularized adipose tissue grafts from human mesenchymal stem cells with bioactive cues and microchannel conduits.

Authors:  Michael S Stosich; Barb Bastian; Nicholas W Marion; Paul A Clark; Gwendolen Reilly; Jeremy J Mao
Journal:  Tissue Eng       Date:  2007-12

Review 10.  Emerging role of adipose tissue hypoxia in obesity and insulin resistance.

Authors:  J Ye
Journal:  Int J Obes (Lond)       Date:  2008-12-09       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.